Piper Sandler Bioinsights Tackling Psychiatric and Mood Disorders.

Piper Sandler_Bioinsights - Tackling Psychiatric and Mood Disorders. David Amsellem SR. RESEARCH ANALYST | Eleanor M. Maughan, Ph.D. SR. RESEARCH STRATEGIST | Zachary Sachar RESEARCH ANALYST | Christopher J. Raymond SR. RESEARCH ANALYST | Piper Sandler does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decisions. This report should be read in conjunction with important disclosure information, including an attestation under Regulation Analyst Certification, found on pages 125 - 128 of this report or at the following site: Piper Sandler Investment Research At Piper Sandler, our biopharma investment research team delivers to clients market-driven and actionable insights across the biotech and pharmaceutical sectors. We build strong partnerships with clients, and they trust our unique perspective to guide their investment strategies. David Amsellem Sr. Research Analyst Joseph Catanzaro, Ph.D. Sr. Research Analyst Christopher Raymond Sr. Research Analyst